Evaluate Safety and Effectiveness of MBX-102 in Type 2 Diabetes Patients With Poor Glycemic Control on Metformin

Clinical trial NCT00814372 · TERMINATED

Trial details

NCT number: NCT00814372
Sponsor: Gilead Sciences
Status: TERMINATED
Phase: Phase 2
Study type: INTERVENTIONAL

Type 2 Diabetes Mellitus

Start date: 2008-12-01
Primary completion: 2010-02-01
Enrollment: 242

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.